Has any clinically relevant hepatic, neurological, pulmonary, ophthalmological, endocrine, psychiatric, or other major systemic disease making implementation of the protocol or interpretation of the study difficult or that would put the subject at risk by participating in the study

Has suspected or diagnosed intra-abdominal or perianal abscess that has not been appropriately treated

Is receiving treatment with any of the following drugs or interventions: CYP2C8 inducers; Monoamine oxidase inhibitors

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

What this study is about